336 related articles for article (PubMed ID: 28262517)
1. Visual acuity, oncologic, and toxicity outcomes with
Patel KR; Prabhu RS; Switchenko JM; Chowdhary M; Craven C; Mendoza P; Danish H; Grossniklaus HE; Aaberg TM; Aaberg T; Reddy S; Butker E; Bergstrom C; Crocker IR
Brachytherapy; 2017; 16(3):646-653. PubMed ID: 28262517
[TBL] [Abstract][Full Text] [Related]
2. Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study.
Saconn PA; Gee CJ; Greven CM; McCoy TP; Ekstrand KE; Greven KM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):844-8. PubMed ID: 20171804
[TBL] [Abstract][Full Text] [Related]
3. Comparative outcomes and toxicities for ruthenium-106 versus palladium-103 in the treatment of choroidal melanoma.
Danish H; Ferris MJ; Balagamwala E; Switchenko JM; Patel KR; Choudhary M; Craven C; Mendoza P; Suh J; Bergstrom C; Grossniklaus HE; M Aaberg T; Singh A; Crocker IR; Khan MK
Melanoma Res; 2018 Apr; 28(2):120-125. PubMed ID: 29303890
[TBL] [Abstract][Full Text] [Related]
4. Palladium-103 plaque radiation therapy for American Joint Committee on cancer T3- and T4-staged choroidal melanomas.
Semenova E; Finger PT
JAMA Ophthalmol; 2014 Feb; 132(2):205-13. PubMed ID: 24287555
[TBL] [Abstract][Full Text] [Related]
5. Plaque radiotherapy for juxtapapillary choroidal melanoma: treatment complications and visual outcomes in 650 consecutive cases.
Sagoo MS; Shields CL; Emrich J; Mashayekhi A; Komarnicky L; Shields JA
JAMA Ophthalmol; 2014 Jun; 132(6):697-702. PubMed ID: 24652552
[TBL] [Abstract][Full Text] [Related]
6. Palladium-103 radiation therapy for small choroidal melanoma.
Semenova E; Finger PT
Ophthalmology; 2013 Nov; 120(11):2353-7. PubMed ID: 23774104
[TBL] [Abstract][Full Text] [Related]
7. A 12-Year Study of Slotted Palladium-103 Plaque Radiation Therapy for Choroidal Melanoma: Near, Touching, or Surrounding the Optic Nerve.
Maheshwari A; Finger PT
Am J Ophthalmol; 2018 Apr; 188():60-69. PubMed ID: 29409899
[TBL] [Abstract][Full Text] [Related]
8. Prescribing to tumor apex in episcleral plaque iodine-125 brachytherapy for medium-sized choroidal melanoma: A single-institutional retrospective review.
Vonk DT; Kim Y; Javid C; Gordon JD; Stea B
Brachytherapy; 2015; 14(5):726-33. PubMed ID: 26051804
[TBL] [Abstract][Full Text] [Related]
9. Palladium-103 ophthalmic plaque radiation therapy for choroidal melanoma: 400 treated patients.
Finger PT; Chin KJ; Duvall G;
Ophthalmology; 2009 Apr; 116(4):790-6, 796.e1. PubMed ID: 19243829
[TBL] [Abstract][Full Text] [Related]
10. Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy.
Wisely CE; Hadziahmetovic M; Reem RE; Hade EM; Nag S; Davidorf FH; Martin D; Cebulla CM
Brachytherapy; 2016; 15(1):12-22. PubMed ID: 26525215
[TBL] [Abstract][Full Text] [Related]
11. Subfoveal choroidal melanoma: pretreatment characteristics and response to plaque radiation therapy.
Newman H; Chin KJ; Finger PT
Arch Ophthalmol; 2011 Jul; 129(7):892-8. PubMed ID: 21746980
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review.
Le BHA; Kim JW; Deng H; Rayess N; Jennelle RL; Zhou SY; Astrahan MA; Berry JL
Brachytherapy; 2018; 17(6):981-989. PubMed ID: 30082188
[TBL] [Abstract][Full Text] [Related]
13. Ruthenium-106 brachytherapy for choroidal melanoma without transpupillary thermotherapy: Similar efficacy with improved visual outcome.
Marinkovic M; Horeweg N; Fiocco M; Peters FP; Sommers LW; Laman MS; Bleeker JC; Ketelaars M; Luyten GP; Creutzberg CL
Eur J Cancer; 2016 Nov; 68():106-113. PubMed ID: 27741435
[TBL] [Abstract][Full Text] [Related]
14. Regression patterns of choroidal melanoma: After palladium-103 (
Maheshwari A; Finger PT
Eur J Ophthalmol; 2018 Nov; 28(6):722-730. PubMed ID: 29788760
[TBL] [Abstract][Full Text] [Related]
15. Plaque radiotherapy for juxtapapillary choroidal melanoma. Visual acuity and survival outcome.
De Potter P; Shields CL; Shields JA; Cater JR; Brady LW
Arch Ophthalmol; 1996 Nov; 114(11):1357-65. PubMed ID: 8906026
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric and late radiation toxicity comparison between iodine-125 brachytherapy and stereotactic radiation therapy for juxtapapillary choroidal melanoma.
Krema H; Heydarian M; Beiki-Ardakani A; Weisbrod D; Xu W; Laperriere NJ; Sahgal A
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):510-5. PubMed ID: 23507292
[TBL] [Abstract][Full Text] [Related]
17. Bilateral simultaneous primary choroidal melanomas: Treated with palladium-103 plaque radiation.
Maheshwari A; Finger PT
Eur J Ophthalmol; 2018 Sep; 28(5):NP1-NP5. PubMed ID: 29575936
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Low-Dose Iodine Plaque Brachytherapy for Juxtapapillary Choroidal Melanoma.
Oellers P; Mowery YM; Perez BA; Stinnett S; Mettu P; Vajzovic L; Light K; Steffey BA; Cai J; Dutton JJ; Buckley EG; Halperin EC; Marks LB; Kirsch DG; Mruthyunjaya P
Am J Ophthalmol; 2018 Feb; 186():32-40. PubMed ID: 29199010
[TBL] [Abstract][Full Text] [Related]
19. Endoresection versus iodine-125 plaque brachytherapy for the treatment of choroidal melanoma.
Caminal JM; Mejia K; Masuet-Aumatell C; Arias L; Piulats JM; Gutierrez C; Pera J; Catala J; Rubio M; Arruga J
Am J Ophthalmol; 2013 Aug; 156(2):334-342.e1. PubMed ID: 23677135
[TBL] [Abstract][Full Text] [Related]
20. Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16.
Melia BM; Abramson DH; Albert DM; Boldt HC; Earle JD; Hanson WF; Montague P; Moy CS; Schachat AP; Simpson ER; Straatsma BR; Vine AK; Weingeist TA;
Ophthalmology; 2001 Feb; 108(2):348-66. PubMed ID: 11158813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
